JP2010285436A5 - - Google Patents

Download PDF

Info

Publication number
JP2010285436A5
JP2010285436A5 JP2010161515A JP2010161515A JP2010285436A5 JP 2010285436 A5 JP2010285436 A5 JP 2010285436A5 JP 2010161515 A JP2010161515 A JP 2010161515A JP 2010161515 A JP2010161515 A JP 2010161515A JP 2010285436 A5 JP2010285436 A5 JP 2010285436A5
Authority
JP
Japan
Prior art keywords
compound according
pharmaceutically acceptable
pharmaceutical formulation
viral
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010161515A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010285436A (ja
Filing date
Publication date
Priority claimed from AUPR8797A external-priority patent/AUPR879701A0/en
Application filed filed Critical
Publication of JP2010285436A publication Critical patent/JP2010285436A/ja
Publication of JP2010285436A5 publication Critical patent/JP2010285436A5/ja
Withdrawn legal-status Critical Current

Links

JP2010161515A 2001-11-09 2010-07-16 二量体化合物および抗ウイルス薬としてのそれらの使用 Withdrawn JP2010285436A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPR8797A AUPR879701A0 (en) 2001-11-09 2001-11-09 Novel chemical compounds and their use

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2003542182A Division JP5183854B2 (ja) 2001-11-09 2002-11-08 二量体化合物および抗ウイルス薬としてのそれらの使用

Publications (2)

Publication Number Publication Date
JP2010285436A JP2010285436A (ja) 2010-12-24
JP2010285436A5 true JP2010285436A5 (2) 2012-07-26

Family

ID=3832616

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003542182A Expired - Fee Related JP5183854B2 (ja) 2001-11-09 2002-11-08 二量体化合物および抗ウイルス薬としてのそれらの使用
JP2010161515A Withdrawn JP2010285436A (ja) 2001-11-09 2010-07-16 二量体化合物および抗ウイルス薬としてのそれらの使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2003542182A Expired - Fee Related JP5183854B2 (ja) 2001-11-09 2002-11-08 二量体化合物および抗ウイルス薬としてのそれらの使用

Country Status (9)

Country Link
US (2) US7214707B2 (2)
EP (1) EP1451183A4 (2)
JP (2) JP5183854B2 (2)
KR (1) KR100942494B1 (2)
CN (1) CN100345842C (2)
AU (2) AUPR879701A0 (2)
CA (1) CA2463835C (2)
TW (1) TW200303196A (2)
WO (1) WO2003040136A1 (2)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR879701A0 (en) 2001-11-09 2001-12-06 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
CN108047153A (zh) * 2017-12-20 2018-05-18 上海朗亿功能材料有限公司 一种低挥发环状碳化二亚胺类化合物及其制备方法
BR112021004266A2 (pt) * 2018-09-06 2021-08-03 Cidara Therapeutics, Inc. conjugados, população de conjugados, composição farmacêutica e métodos para o tratamento de um sujeito com uma infecção viral e para o tratamento profilático
TWI861205B (zh) 2019-09-06 2024-11-11 美商席達拉醫療有限公司 用於治療病毒感染之組合物及方法
CN110981753A (zh) * 2019-12-19 2020-04-10 山东华阳农药化工集团有限公司 一种碳酸二甲酯法制备二苯基乙烷二异氰酸酯及其应用
CN110903216A (zh) * 2019-12-19 2020-03-24 山东华阳农药化工集团有限公司 一种固体光气法制备二苯基乙烷二异氰酸酯及其应用
CN110981754A (zh) * 2019-12-19 2020-04-10 山东华阳农药化工集团有限公司 一种二苯基乙烷二异氰酸酯及其制备方法
US20230364251A1 (en) * 2020-08-06 2023-11-16 Cidara Therapeutics, Inc. Methods for the synthesis of protein-drug conjugates
WO2022032188A1 (en) * 2020-08-06 2022-02-10 Cidara Therapeutics, Inc. Methods for the synthesis of protein-drug conjugates
CA3211494A1 (en) * 2021-03-11 2022-09-15 Leslie W. Tari Protein-drug conjugates for antiviral therapy
US20250144220A1 (en) * 2021-12-30 2025-05-08 Suzhou Ark Biopharmaceutical Co., Ltd. Conjugate for preventing and treating viral infections and use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3409295A (en) * 1994-08-18 1996-03-14 Ariad Gene Therapeutics, Inc. Regulatable elimination of gene expression, gene product function and engineered host cells
GB9516276D0 (en) * 1995-08-08 1995-10-11 Biota Scient Management Chemical compounds
HU223099B1 (hu) * 1996-03-01 2004-03-29 Biota Scientific Managemant Pty. Ltd. Eljárás influenzavírus kimutatására és az eljárásban alkalmazható vegyületek
AUPP913999A0 (en) * 1999-03-12 1999-04-01 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
AUPR001000A0 (en) 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
AUPR879701A0 (en) 2001-11-09 2001-12-06 Biota Scientific Management Pty Ltd Novel chemical compounds and their use

Similar Documents

Publication Publication Date Title
JP2010285436A5 (2)
JP2010270130A5 (2)
JP2009535352A5 (2)
JP2010132695A5 (2)
JP2011528713A5 (2)
JP2018513188A5 (2)
JP2017515840A5 (2)
SI2709613T1 (en) Procedures for the treatment of HCV
JP2013507439A5 (2)
JP2014530874A5 (2)
JP2015534562A5 (2)
JP2011225596A5 (2)
JP2013515022A (ja) 相乗的抗ウイルス組成物及びその使用
RU2007119721A (ru) Частицы для лечения легочной инфекции
JP2014510130A5 (2)
US20220387455A1 (en) Treatment of moderate to severe influenza
JP2011006424A5 (2)
MX2018013475A (es) Acido carboxilico para tratar/prevenir congestion nasal.
CN103446051A (zh) 含有帕拉米韦和/或其衍生物制剂的给药方法
CA2525202A1 (en) Use of alpha interferon, ribavirin, dsrna and neuraminidase inhibitors to treat avian influenza
RU2010120806A (ru) Композиции для ингаляции, содержащие кислоту монтелукаст и ингибитор pde-4 или ингаляционный кортикостероид
RU2014136096A (ru) Лекарственное средство для лечения и профилактики заболеваний верхних и нижних дыхательных путей различной этиологии, его применение и метод лечения на его основе
CA2462337A1 (en) Dimeric compounds and their use as anti-viral agents
RU2012116226A (ru) Бронхолитическое средство на основе простагландина
JP2011016804A5 (2)